XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 58,169 $ 71,722
Marketable securities 122,924 149,680
Research and development tax credit receivable 2,493 3,326
Prepaid expenses and other current assets 22,234 38,726
Total current assets 205,820 263,454
Property and equipment, net 304 359
Operating lease right-of-use assets 2,070 2,604
Goodwill 16,836 16,836
Research and development tax credit receivable 961 3,445
Other non-current assets 38,098 24,939
Total assets 264,089 311,637
Current liabilities:    
Current portion of operating lease liability 504 474
Accounts payable 6,874 2,934
Accrued expenses 8,738 6,501
Other current liabilities 1,471 5,200
Total current liabilities 17,587 15,109
Long-term debt 142,086 128,210
Long-term operating lease liability 1,460 1,840
Other non-current liabilities 3,999 4,212
Total liabilities 165,132 149,371
Shareholders’ equity:    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at September 30, 2021 and 488 issued and outstanding at December 31, 2020, respectively 5 5
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 58,616 issued and outstanding at September 30, 2021 and 58,396 issued and outstanding at December 31, 2020 586 583
Additional paid-in capital 546,565 566,916
Accumulated deficit (425,455) (384,187)
Accumulated other comprehensive loss (22,744) (21,051)
Total shareholders’ equity 98,957 162,266
Total liabilities and shareholders’ equity $ 264,089 $ 311,637